June 1, 2024 ファルストマ株式会社 代表取締役CEO 久保田雅彦 (Head Office: Tokyo; President: Masahiko Kubota) and Department of Chemistry, Faculty of Medicine, Keio University (Principal Investigator: Associate Professor Mari Kubota) have signed a joint research agreement to realize an oral insulin drug using UFB (Ultra Fine Bubble) water. Based on this...
Archive for category: news
Notice of Completion of Seed Investment Round
cb-luckyboy, , news, 0
May 17, 2024 Pharstoma Inc. CEO Masahiko Kubota Pharstoma Co., Ltd. (Headquarters: Toranomon, Minato-ku, Tokyo; President and CEO: Masahiko Kubota) is pleased to announce that our seed investment round has successfully closed, having received sufficient support from our investors. As a result, we are now able to commence the...
Statement of wage increase plan for employees
cb-luckyboy, , news, 0
22nd April 2024 The company plans to be established in 2024 and to begin hiring employees in 2024. In addition, in view of the recent inflation and ease of working for employees, we will publish the following statement in order to participate as a member of a better society....
Signed a consulting agreement with PQE Japan K.K.
cb-luckyboy, , news, 0
March 25, 2024 Pharstoma Inc. (Headquarters: Toranomon, Minato-ku, Tokyo; President: Masahiko Kubota) has signed a comprehensive consulting agreement with PQE Japan Co., Ltd. (Headquarters: Abeno-ku, Osaka; President: Andrea Salvadori). By entering into an agreement with PQE Japan for drug discovery and development, Pharstoma plans to proceed with clinical...